Mario Balsa· @MarioBalsaMD · X·· 3 天前评分70
正文 · 机器翻译
从讲台到实践，实时呈现！
@OncoAlert #Podium2Screen 将最终的 LITESPARK-011 数据直接从 #ESMO26 带来！ 还有谁比 @DrDanielHeng 更适合为其解读 ✨
幻灯片只是一方面……但专家背景才是 OncoAlert 的精华 😉
27 浏览 · 0 赞 · 0 转发 · 0 回复
OncoAlert 🚨 #ESMO26 #Podium2Screen LITESPARK-011 final analysis in #RCC Our @OncoAlert founding faculty @DanielHengMD 🇨🇦 presents belzutifan + lenvatinib vs cabo after anti–PD-(L)1: ➡️ PFS HR 0.74 (14.8 vs 10.8 mo) ➡️ ORR 53% vs 40%, DOR 22.0 vs 11.9 mo ➡️ OS HR 0.85, not significant 👇 #KidneyCancer #GUOnc Pinging Our Faculty @DrChoueiri, @tompowles1, @apolo_andrea, @neerajaiims, @montypal, @Silke_Gillessen, @AOmlin, @brian_rini, @PGrivasMDPhD, @TiansterZhang, @amerseburger, @DrDanielHeng, @HHammersMD, @scocmem, @AndreaNecchi, @AmandaNizamMD, @drenriquegrande, @nataliagandur, @AlbigesL, @cdanicas, @declangmurphy, @seanmmcbride, @shilpaonc, @DrRanaMcKay, @scserendipity1, @DrYukselUrun, @ravikanesvaran, @BraunMDPhD, @EfstathiouEleni, @mzugman, @crisbergerot, @niklas_kluemper @Markuseckstein3在 X 查看被引用的帖子
来源：Mario Balsa · x.com